Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8211327 | International Journal of Radiation Oncology*Biology*Physics | 2018 | 26 Pages |
Abstract
Radiation plus ADT may result in improved QALE compared with RP for intermediate- to high-risk prostate cancer. Although biochemical failure is similar between treatment groups, there is a higher rate of developing multiple toxicities among patients treated with upfront RP.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jennifer A. MD, MHSc, W. Robert MD, MS, MEd, Junzo MD, Robert MD, MS, Rodney J. MD, Evan R. MD, MPH,